منابع مشابه
Therapeutic Strategies in Heart Failure
Clyde W. Yancy and James B. Young, eds 256 pages. Oxford, UK: Clinical Publishing; 2008. $77.00. ISBN 1–904392–40–7 The sobering statistics on heart failure in the United States are often repeated: the incidence approaches 10 per 1000 population after 65 years of age; the lifetime risk for both men and women over age 40 is 1 in 5; 1.1 million hospital discharges occur per year, with estimated c...
متن کاملTherapeutic Strategies for Sleep Apnea in Hypertension and Heart Failure
Sleep-disordered breathing (SDB) causes hypoxemia, negative intrathoracic pressure, and frequent arousal, contributing to increased cardiovascular disease mortality and morbidity. Obstructive sleep apnea syndrome (OSAS) is linked to hypertension, ischemic heart disease, and cardiac arrhythmias. Successful continuous positive airway pressure (CPAP) treatment has a beneficial effect on hypertensi...
متن کاملSarcopenia in heart failure: mechanisms and therapeutic strategies
Chronic heart failure (CHF) is a highly prevalent condition among the elderly and is associated with considerable morbidity, institutionalization and mortality. In its advanced stages, CHF is often accompanied by the loss of muscle mass and strength. Sarcopenia is a geriatric syndrome that has been actively studied in recent years due to its association with a wide range of adverse health outco...
متن کاملTherapeutic Targets in Heart Failure
From the *Heart Pittsburgh Schoo Cardiomyopathy C California; zCente School of Medici University, Atlanta Siemens; has receiv purposes; and has r The Pittsburgh F GlaxoSmithKline, Relypsa, Scios, St. as the Eliot Cord Ahmanson Found ew therapeutic targets, agents, and strategies are needed to prevent and treat heart failure (HF) after a decade of failed research efforts to improve long-term pat...
متن کاملDiagnostic and therapeutic problems in heart failure.
Heart failure (HF), affecting an increasing number of patients, is associated with several diagnostic, therapeutic, socioeconomic problems. Despite considerable advances, prognosis in HF--both in systolic failure and in that with preserved systolic function--is poor, which in part results from not the fully understood pathophysiology of this disease, and therapeutic approaches used at present. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2008
ISSN: 0009-7322,1524-4539
DOI: 10.1161/circulationaha.108.772970